These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8738813)

  • 41. [Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients].
    Kakuk G; Kárpáti I; Mátyus J
    Orv Hetil; 1990 Oct; 131(43):2365-6, 2369-71. PubMed ID: 2234936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Early efficacy of recombinant human erythropoietin in treatment of anemia].
    Huang S; Yang L; Huang M
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):317-9. PubMed ID: 9389072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M; Giansanti R; Boemi M; Baldassari M; Baldini S; Pierangeli T; Radicioni R; Fumelli P; Panichi N
    Minerva Urol Nefrol; 1992; 44(2):155-9. PubMed ID: 1411865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Erythrocyte levels of ALA-dehydrase and uro-synthetase in chronic renal insufficiency (author's transl)].
    Tabernero Romo JM; Pérez Sandoval D; Rodríguez Commes JL; Rico Sánchez J; Macías Núñez JF; Corbacho Becerra L; Juanes A; de Castro S
    Med Clin (Barc); 1981 Jun; 77(2):69-71. PubMed ID: 7321629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heme biosynthesis and porphyrin studies in chronic renal failure patients following kidney transplantation.
    el-Far M; Sobh M; Ghoniem M
    Int Urol Nephrol; 1991; 23(5):503-9. PubMed ID: 1938250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
    Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
    Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal proteins and chronic treatment with low-dose erythropoietin.
    Bellizzi V; de Nicola L; Ames P; Libertino R; Terracciano V; Cianciaruso B
    J Lab Clin Med; 1997 Feb; 129(2):193-9. PubMed ID: 9016855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum.
    Donnelly SM; Ali MA; Churchill DN
    Am J Kidney Dis; 1990 Nov; 16(5):447-51. PubMed ID: 2239935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heme biosynthesis in sideroblastic anemia.
    Pasanen AV; Salmi M; Vuopio P; Tenhunen R
    Int J Biochem; 1980; 12(5-6):969-74. PubMed ID: 7450158
    [No Abstract]   [Full Text] [Related]  

  • 54. The anemia of chronic renal failure: in vitro response of bone marrow to erythropoietin.
    Wallner SF; Ward HP; Vautrin R; Alfrey AC; Mishell J
    Proc Soc Exp Biol Med; 1975 Sep; 149(4):939-44. PubMed ID: 1166090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC
    Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.
    Labonia WD
    Am J Kidney Dis; 1995 Nov; 26(5):757-64. PubMed ID: 7485128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.
    Suzuki Y; Ogura Y; Otsubo O; Mimura N; Takaku F; Maeda T
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1019-23. PubMed ID: 1479730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.
    Akizawa T; Kinugasa E; Kitaoka T; Koshikawa S
    Nephron; 1991; 58(4):400-6. PubMed ID: 1922603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.